• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳铁蛋白及其纳米制剂在罕见眼病中的应用。

Lactoferrin and its nano-formulations in rare eye diseases.

机构信息

Departments of Biophysics, All India Institute of Medical Sciences, New Delhi, India.

Tirupati Eye Centre and Research Institute, Noida, Uttar Pradesh, India.

出版信息

Indian J Ophthalmol. 2022 Jul;70(7):2328-2334. doi: 10.4103/ijo.IJO_303_22.

DOI:10.4103/ijo.IJO_303_22
PMID:35791114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9426081/
Abstract

Lactoferrin (LF) is an iron-binding glycoprotein released from mucous secreting cells and neutrophils. LF can be used in a broad range of eye diseases related to the retina, cornea, and optic nerve. The retina is particularly affected by oxidative stress inside the photoreceptor being constantly exposed to light which induces accumulation of reactive oxygen species (ROS) in the retinal pigmented epithelium (RPE) causing damage to photoreceptor recycling. Retinitis pigmentosa (RP) and macular degeneration are inherited retinopathies that consist of different disease-causing genes, that cause mutations with highly varied clinical consequences. Age-related macular degeneration is a chronic disease of the retina and one of the major causes of sight loss. This review provides an application of lactoferrin and LF-based nano-formulations or nanoparticles in the field of retinal diseases or corneal diseases such as retinitis pigmentosa, retinoblastoma, age-related macular degeneration (AMD), keratoconus and uveitis. Several studies have found that lactoferrin's antibacterial activity is not limited to its iron sequestration, but also its ability as a nanoparticle that acts as a carrier to deliver drugs by crossing the blood-retina barrier (BRB) and its involvement in cell cycle control, which is not possible by many transferrin proteins.

摘要

乳铁蛋白(LF)是一种从黏液分泌细胞和中性粒细胞中释放出来的铁结合糖蛋白。LF 可广泛用于与视网膜、角膜和视神经相关的各种眼部疾病。视网膜特别容易受到光感受器内氧化应激的影响,光感受器不断暴露在光线下会导致视网膜色素上皮(RPE)中活性氧(ROS)的积累,从而对光感受器的再循环造成损害。色素性视网膜炎(RP)和年龄相关性黄斑变性是遗传性视网膜病变,由不同的致病基因引起,这些基因的突变会产生高度不同的临床后果。年龄相关性黄斑变性是一种慢性视网膜疾病,也是导致视力丧失的主要原因之一。本综述介绍了乳铁蛋白及其基于纳米制剂或纳米颗粒在视网膜疾病或角膜疾病中的应用,如色素性视网膜炎、视网膜母细胞瘤、年龄相关性黄斑变性(AMD)、圆锥角膜和葡萄膜炎。一些研究发现,乳铁蛋白的抗菌活性不仅限于其铁螯合作用,还与其作为纳米颗粒的能力有关,作为纳米颗粒可以通过血视网膜屏障(BRB)输送药物,并参与细胞周期控制,这是许多转铁蛋白蛋白所不可能的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/f59d8a80680c/IJO-70-2328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/06bd2ceb6a4a/IJO-70-2328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/54484a8d0e1d/IJO-70-2328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/740225f4d7b4/IJO-70-2328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/f59d8a80680c/IJO-70-2328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/06bd2ceb6a4a/IJO-70-2328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/54484a8d0e1d/IJO-70-2328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/740225f4d7b4/IJO-70-2328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04f/9426081/f59d8a80680c/IJO-70-2328-g004.jpg

相似文献

1
Lactoferrin and its nano-formulations in rare eye diseases.乳铁蛋白及其纳米制剂在罕见眼病中的应用。
Indian J Ophthalmol. 2022 Jul;70(7):2328-2334. doi: 10.4103/ijo.IJO_303_22.
2
Oxidative Stress and Microglial Response in Retinitis Pigmentosa.氧化性应激与视网膜色素变性中的小胶质细胞反应。
Int J Mol Sci. 2020 Sep 28;21(19):7170. doi: 10.3390/ijms21197170.
3
Retinal Pigment Epithelium Remodeling in Mouse Models of Retinitis Pigmentosa.视网膜色素上皮重塑在视网膜色素变性的小鼠模型中。
Int J Mol Sci. 2021 May 20;22(10):5381. doi: 10.3390/ijms22105381.
4
Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency.小胶质细胞抑制因 MerTK 吞噬受体缺陷导致的视网膜变性。
Front Immunol. 2020 Jul 16;11:1463. doi: 10.3389/fimmu.2020.01463. eCollection 2020.
5
Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.人视网膜中针对tau蛋白、淀粉样前体蛋白和β-淀粉样蛋白的免疫反应性。
Invest Ophthalmol Vis Sci. 1995 Jan;36(1):24-31.
6
[Progress in pathogenesis and therapeutic research in retinitis pigmentosa and age-related macular degeneration].视网膜色素变性和年龄相关性黄斑变性的发病机制及治疗研究进展
Nippon Ganka Gakkai Zasshi. 2004 Dec;108(12):750-68; discussion 769.
7
Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.视网膜色素变性中的血视网膜屏障破坏:光镜和电镜免疫定位
Histol Histopathol. 1995 Oct;10(4):913-23.
8
Iron, the retina and the lens: a focused review.铁、视网膜和晶状体:重点综述。
Exp Eye Res. 2010 Jun;90(6):664-78. doi: 10.1016/j.exer.2010.03.003. Epub 2010 Mar 15.
9
Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.纤连蛋白 3 敲除小鼠表现出角膜功能障碍,但视网膜完整性保持正常。
J Mol Med (Berl). 2020 Nov;98(11):1639-1656. doi: 10.1007/s00109-020-01974-z. Epub 2020 Sep 22.
10
Iron and age-related macular degeneration.铁与年龄相关性黄斑变性
Klin Oczna. 2009;111(4-6):174-7.

引用本文的文献

1
Exploring Tc-Labeled Iron-Binding Glycoprotein Nanoparticles as a Potential Nanoplatform for Sentinel Lymph Node Imaging: Development, Characterization, and Radiolabeling Studies.探索锝标记的铁结合糖蛋白纳米颗粒作为前哨淋巴结成像的潜在纳米平台:研发、表征及放射性标记研究
ACS Omega. 2024 Oct 1;9(41):42410-42422. doi: 10.1021/acsomega.4c05991. eCollection 2024 Oct 15.
2
Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.乳铁蛋白递送系统的开发、优化及临床相关性:聚焦眼部递送
Pharmaceutics. 2024 Jun 14;16(6):804. doi: 10.3390/pharmaceutics16060804.
3
Spotlight on iron and ferroptosis: research progress in diabetic retinopathy.

本文引用的文献

1
Modern treatment of retinoblastoma: A 2020 review.现代视网膜母细胞瘤治疗:2020 年回顾。
Indian J Ophthalmol. 2020 Nov;68(11):2356-2365. doi: 10.4103/ijo.IJO_721_20.
2
Lactoferrin Concentration in Human Tears and Ocular Diseases: A Meta-Analysis.人泪液乳铁蛋白浓度与眼部疾病:一项荟萃分析。
Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):9. doi: 10.1167/iovs.61.12.9.
3
Iron Absorption is Greater from Apo-Lactoferrin and is Similar Between Holo-Lactoferrin and Ferrous Sulfate: Stable Iron Isotope Studies in Kenyan Infants.
聚焦铁和铁死亡:糖尿病视网膜病变研究进展。
Front Endocrinol (Lausanne). 2023 Sep 13;14:1234824. doi: 10.3389/fendo.2023.1234824. eCollection 2023.
4
Molecular Genetic Analysis of the Autosomal Recessive Non-Syndromic Inherited Retinitis Pigmentosa.常染色体隐性非综合征性遗传性视网膜色素变性的分子遗传学分析
Cureus. 2023 Apr 21;15(4):e37933. doi: 10.7759/cureus.37933. eCollection 2023 Apr.
5
Colostrum Proteins in Protection against Therapy-Induced Injuries in Cancer Chemo- and Radiotherapy: A Comprehensive Review.初乳蛋白在预防癌症化疗和放疗引起的损伤中的作用:综述
Biomedicines. 2023 Jan 3;11(1):114. doi: 10.3390/biomedicines11010114.
乳铁蛋白的铁吸收率高于全铁结合乳铁蛋白,且与硫酸亚铁相似:肯尼亚婴儿的稳定铁同位素研究。
J Nutr. 2020 Dec 10;150(12):3200-3207. doi: 10.1093/jn/nxaa226.
4
Targeting cancer with lactoferrin nanoparticles: recent advances.用乳铁蛋白纳米颗粒靶向治疗癌症:最新进展
Nanomedicine (Lond). 2020 Sep;15(21):2071-2083. doi: 10.2217/nnm-2020-0090. Epub 2020 Aug 11.
5
Atypical and ultra-rare Usher syndrome: a review.非典型及极罕见的 Usher 综合征:综述。
Ophthalmic Genet. 2020 Oct;41(5):401-412. doi: 10.1080/13816810.2020.1747090. Epub 2020 May 6.
6
Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype.乳铁蛋白免疫复合物通过将肿瘤相关巨噬细胞重置为 M1 表型来介导抗肿瘤作用。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000339.
7
Nano based drug delivery systems: recent developments and future prospects.基于纳米的药物传递系统:最新进展与未来展望。
J Nanobiotechnology. 2018 Sep 19;16(1):71. doi: 10.1186/s12951-018-0392-8.
8
Age-Related Dry Eye Lactoferrin and Lactobionic Acid.年龄相关性干眼与乳铁蛋白和乳糖酸
Ophthalmic Res. 2018;60(2):94-99. doi: 10.1159/000489093. Epub 2018 Jun 19.
9
Lactoferrin in a Context of Inflammation-Induced Pathology.炎症诱导病理情况下的乳铁蛋白。
Front Immunol. 2017 Nov 6;8:1438. doi: 10.3389/fimmu.2017.01438. eCollection 2017.
10
Higher Expression of Toll-Like Receptors 2 and 4 in Blood Cells of Keratoconus Patiens.角膜膨隆症患者血细胞中 Toll 样受体 2 和 4 的高表达。
Sci Rep. 2017 Oct 11;7(1):12975. doi: 10.1038/s41598-017-13525-7.